[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-365751-en":59,"doc-seo-365751-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":72,"language_code":73,"site_id":74,"html_lang":73,"table_of_contents":75,"faqs":76,"seo_title":77,"seo_description":66,"update_tm":78,"read_time":79,"preview_page_count":19,"preview_urls":80},365751,1099523885074,"Riley West","https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Research hotspots and trends in lung cancer immunotherapy are revealed by a bibliometric study spanning the years 2004 to 2024","To summarize the research status of lung cancer immunotherapy using bibliometrics, CiteSpace software analyzes all lung cancer immunotherapy literature indexed in Web of Science from 2004 to 2024. The search retrieves 1702 publications, with growth accelerating after 2014. Tumor microenvironment and dendritic cells are the most intensively studied areas, while key contributors include He Jie, Chinese Academy of Medical Sciences–Peking Union Medical College, and China. The trajectory and main hotspots—tumor microenvironment, blockade, nivolumab, resistance, and chemotherapy—are examined, and future work may focus on melanoma, antibody, dendritic cells, non-small cell lung cancer, and CTLA-4 blockade.","RESEARCH ARTICLE     \nResearch hotspots and trends in lung cancer immunotherapy are revealed by a bibliometric study spanning the years 2004 to 2024  \nXu Sun, Hongxia Cheng, Jing Zhao, Zhihui Jia, and Qiong Xu  \nDepartment of Hematology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China  \nABSTRACT  \nTo summarize the research status of lung cancer immunotherapy using bibliometrics. CiteSpace software was used to analyze all literature on lung cancer immunotherapy collected from the Web of Science (WOS) database from 2004 to 2024. A total of 1702 publications on lung cancer immunotherapy were searched, and the number of articles increased more rapidly after 2014. Two areas intensively studied by the discipline are tumor microenvironment and dendritic cells. He, Jie, Chinese Academy of Medical Sciences – Peking Union Medical College, and China of America were the authors, institutions, and countries with the most. The research trajectory in the use of immunotherapy for lung cancer is thoroughly examined in this article. With tumor microenvironment, blockade, nivolumab, resistance, and chemotherapy being the primary research hotspots. Future studies might concentrate on melanoma, antibody, dendritic cells, non-small cell lung cancer, and ctla 4 blockade.  \nARTICLE HISTORY  \nReceived 6 March 2025 Revised 13 May 2025 Accepted 23 May 2025  \nKEYWORDS  \nImmunotherapy; lung cancer; knowledge mapping; CiteSpace; bibliometric analysis; web of science  \nIntroduction  \nGlobally, lung cancer continues to be a leading cause of death.1–4 About 15% of all instances oflung cancer are small cell lung cancer (SCLC), a very aggressive and resistant to treatment type of the disease.5,6 Up to 200,000 people are thought to die from SCLC each year, with an estimated 250,000 new cases occurring globally.7 Males are somewhat more likely than females to develop SCLC, however the gender difference is narrowing. SCLC onset is most common in those over 50. Additionally, smoking length and intensity are positively connected with the incidence ofmorbidity, and the morbidity linked to SCLC includes risk factors such as tobacco and environmental pollution.8,9 Variations in the frequency ofSCLC are caused by both racial and geographic differences; African Americans have a greater incidence than Caucasians, and the rate of SCLC is declining in high-income regions and nations.10–12 Rapid prolongation and early metastasis dissemination are characteristics ofSCLC, which results in nearly 70% of cases having distant metastases at diagnosis anda 5-y survival rate of only 6.4%, compared to 25–33% for patients diagnosed at an early stage 15, highlighting the urgent need, given the current epidemiological situation, for the development of medications and therapy strategies for SCLC.13  \nUnderstanding lung cancer immunotherapy research’s present condition and hotspots is difficult due to the field’s rapid evolution. On the one hand, a significant development in immunotherapy for patients with lung cancer has resulted from an increase in published studies. It is challenging for researchers to obtain a comprehensive picture of the state oflung cancer immunotherapy research, nevertheless, because of the dispersed and duplicated nature of these numerous trials. Scientific analysis that is quantitative may be done  \nwith CiteSpace software. CiteSpace is a web-based Java application for data analysis and visualization.14 It is a unique and influential application software in the field of information visualization analysis.15–17 The Web of Science (WOS) database maybe searched to provide a comprehensive understanding of the field’s present state, hotspots, and upcoming research trends.15, 18–20  \nMethod  \nSource of literature  \nWe enter the subject terms into the WOS Core Collection TI/AB = (“Lung Adenocarcinomas” OR “Lung Adenocarcinomas” OR“Lung Adenocarcinoma” OR “Adenocarcinoma, Lun","cbCaimYHdXdwIxWM","https://ap.wps.com/l/cbCaimYHdXdwIxWM","pdf",11787183,"English","en",105,"# Abstract\n# Keywords\n# Introduction\n# Method\n## Source of literature\n## Analysis software","[{\"question\":\"Which database and software were used to analyze lung cancer immunotherapy research from 2004 to 2024?\",\"answer\":\"The study used the Web of Science (WOS) database and analyzed the literature with CiteSpace software.\"},{\"question\":\"How many publications were retrieved and how did publication growth change over time?\",\"answer\":\"A total of 1702 publications were retrieved, and the number of articles increased more rapidly after 2014.\"},{\"question\":\"What research hotspots and future directions are highlighted in the bibliometric results?\",\"answer\":\"Primary hotspots include tumor microenvironment, blockade, nivolumab, resistance, and chemotherapy. Future studies may focus on melanoma, antibodies, dendritic cells, non-small cell lung cancer, and CTLA-4 blockade.\"}]","Research hotspots and trends in lung cancer immunotherapy are revealed by a bibliometric study spanning the years 2004 to 2024 | PDF",1790162134,25,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11c8e628a837b0f6a28e4476e9570002.webp",983,1280,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88875f3672c83cff734b09e62a78e6e8.webp",982,1278,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6d3f078826084cd9b15bb11671e016c.webp",981,1277,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12b5928e5d57e39f37fcb5b5316693ef.webp",980,1276,{"code":4,"msg":99,"data":100},"ok",{"site_id":74,"language":73,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"research-hotspots-and-trends-in-lung-cancer-immunotherapy-are-revealed-by-a-bibliometric-study-spanning-the-years-2004-to-2024","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/research-hotspots-and-trends-in-lung-cancer-immunotherapy-are-revealed-by-a-bibliometric-study-spanning-the-years-2004-to-2024/365751/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":73,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/research-hotspots-and-trends-in-lung-cancer-immunotherapy-are-revealed-by-a-bibliometric-study-spanning-the-years-2004-to-2024/365751.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":135,"interactionType":136,"userInteractionCount":34},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"Which database and software were used to analyze lung cancer immunotherapy research from 2004 to 2024?","Question",{"text":145,"@type":146},"The study used the Web of Science (WOS) database and analyzed the literature with CiteSpace software.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How many publications were retrieved and how did publication growth change over time?",{"text":150,"@type":146},"A total of 1702 publications were retrieved, and the number of articles increased more rapidly after 2014.",{"name":152,"@type":143,"acceptedAnswer":153},"What research hotspots and future directions are highlighted in the bibliometric results?",{"text":154,"@type":146},"Primary hotspots include tumor microenvironment, blockade, nivolumab, resistance, and chemotherapy. Future studies may focus on melanoma, antibodies, dendritic cells, non-small cell lung cancer, and CTLA-4 blockade.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":74},1790708617]